ContractLicense, Supply, and Distribution Agreement • August 2nd, 2023 • Evolus, Inc. • Pharmaceutical preparations • England and Wales
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SUCH EXCLUDED INFORMATION HAS BEEN MARKED WITH “[***]”.
THIRD AMENDMENT TO LOAN AGREEMENTLoan Agreement • August 2nd, 2023 • Evolus, Inc. • Pharmaceutical preparations • New York
IN WITNESS WHEREOF, Borrower has caused this Tranche B Note to be duly executed by one of its officers thereunto duly authorized on the date hereof.
5TH AMENDMENTLicense & Supply Agreement • August 2nd, 2023 • Evolus, Inc. • Pharmaceutical preparations
This 5TH AMENDMENT (“5th Amendment”) is made and entered into on April 20th, 2023 (“5th Amendment Effective Date”) by and between Daewoong Pharmaceutical Co., Ltd. (“DAEWOONG”) and Evolus, Inc. EVOLUS and
